Multiple targets of carbon monoxide gas in the intestinal inflammation

详细信息    查看全文

• 作者：Yuji Naito ; ^{ynaito@koto.kpu-m.ac.jp" class="auth_mail" title="E-mail the corresponding author} ; Tomohisa Takagi ; Kazuhiko Uchiyama ; Kazuhiro Katada ; Toshikazu Yoshikawa
• 关键词：Carbon monoxide ; CO-Releasing molecule ; Inflammatory bowel disease ; Epithelial restitution ; T cell differentiation ; Macrophage activation
• 刊名：Archives of Biochemistry and Biophysics
• 出版年：2016
• 出版时间：1 April 2016
• 年：2016
• 卷：595
• 期：Complete
• 页码：147-152
• 全文大小：1331 K

文摘

Inflammatory bowel diseases (IBDs) such as ulcerative colitis and Crohn's disease are chronic relapsing and remitting inflammatory disorders of the intestinal tract. It is important to investigate the precise pathogenesis of IBD, to evaluate new anti-inflammatory agents, and to develop novel drugs. Carbon monoxide (CO) has emerged as an important regulator of acute and chronic inflammation of the gastrointestinal tract. The mechanism underlying its anti-inflammatory effects is only partially understood. Recent reports have demonstrated that CO could play a role in the functional modulation of epithelial and immunological cells in the intestine. In this short review, we have highlighted the recent findings that CO stimulates the epithelial cell restitution and FGF production from myofibroblasts. CO was also shown to regulate T cell activation and differentiation, and to activate macrophages. Finally, we have discussed the direction of translational research with respect to launching a novel agent for releasing CO in the intestine.